Accession Number: | 0001567619-19-018899 |
Date: | 2019-09-27 |
Issuer: | BIOMARIN PHARMACEUTICAL INC (BMRN) |
Original Submission Date: |
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL, CA 94901
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-27 | M | 1,000 | a | $21.51 | 327,520 | direct | ||
COMMON STOCK | 2019-09-27 | 0 | $0.00 | 181,341 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY COMMON STOCK) | 21.51 | 2019-09-27 | deemed execution date | M | 1,000 (d) | 2010-11-12 | 2020-05-11 | common stock 1,000 | $21.51 | 138,000 | direct |
ID | footnote |
---|---|
f1 | reflects the number of options outstanding after the transactions from this specific stock option grant. |